BrainStorm Executive Leadership to Participate in DUPHAT 2026; Executive Chairman Peter J. Pitts Invited to Deliver Two Keynote Addresses and Moderate Panel Sessions
BrainStorm Cell Therapeutics executives will attend the DUPHAT conference in Dubai, where Executive Chairman Peter J. Pitts is scheduled to deliver keynote addresses on regulatory policy and NIH funding models. Concurrently, CEO Chaim Lebovits and the executive team plan to hold meetings with regional health regulators and investors to discuss the NurOwn platform and the upcoming Phase 3b ENDURANCE trial.
Key figures
- Drug Name
- NurOwn
- Phase Of Trial
- Phase 3b
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.